118 related articles for article (PubMed ID: 22887910)
1. Strategic Assay Selection for analytics in high-throughput process development: case studies for downstream processing of monoclonal antibodies.
Konstantinidis S; Kong S; Chhatre S; Velayudhan A; Heldin E; Titchener-Hooker N
Biotechnol J; 2012 Oct; 7(10):1256-68. PubMed ID: 22887910
[TBL] [Abstract][Full Text] [Related]
2. Identifying analytics for high throughput bioprocess development studies.
Konstantinidis S; Kong S; Titchener-Hooker N
Biotechnol Bioeng; 2013 Jul; 110(7):1924-35. PubMed ID: 23334907
[TBL] [Abstract][Full Text] [Related]
3. Quantitative high throughput analytics to support polysaccharide production process development.
Noyes A; Godavarti R; Titchener-Hooker N; Coffman J; Mukhopadhyay T
Vaccine; 2014 May; 32(24):2819-28. PubMed ID: 24576849
[TBL] [Abstract][Full Text] [Related]
4. A label-free methodology for selective protein quantification by means of absorption measurements.
Hansen SK; Skibsted E; Staby A; Hubbuch J
Biotechnol Bioeng; 2011 Nov; 108(11):2661-9. PubMed ID: 21755495
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening techniques for rapid PEG-based precipitation of IgG4 mAb from clarified cell culture supernatant.
Knevelman C; Davies J; Allen L; Titchener-Hooker NJ
Biotechnol Prog; 2010; 26(3):697-705. PubMed ID: 20014099
[TBL] [Abstract][Full Text] [Related]
6. Strategic assay deployment as a method for countering analytical bottlenecks in high throughput process development: case studies in ion exchange chromatography.
Konstantinidis S; Heldin E; Chhatre S; Velayudhan A; Titchener-Hooker N
Biotechnol Prog; 2012; 28(5):1292-302. PubMed ID: 22740190
[TBL] [Abstract][Full Text] [Related]
7. Small-scale and automatable high-throughput compositional analysis of biomass.
DeMartini JD; Studer MH; Wyman CE
Biotechnol Bioeng; 2011 Feb; 108(2):306-12. PubMed ID: 20830680
[TBL] [Abstract][Full Text] [Related]
8. Examination of a genetic algorithm for the application in high-throughput downstream process development.
Treier K; Berg A; Diederich P; Lang K; Osberghaus A; Dismer F; Hubbuch J
Biotechnol J; 2012 Oct; 7(10):1203-15. PubMed ID: 22700464
[TBL] [Abstract][Full Text] [Related]
9. High-throughput methods for miniaturization and automation of monoclonal antibody purification processes.
Treier K; Hansen S; Richter C; Diederich P; Hubbuch J; Lester P
Biotechnol Prog; 2012; 28(3):723-32. PubMed ID: 22467605
[TBL] [Abstract][Full Text] [Related]
10. A 2DE approach for high-throughput antigen separation applicable to mAb production.
Carta F; Lobina O; Mannu F; Ferru E; Pantaleo A; Orrù M; Turrini F
Electrophoresis; 2012 Aug; 33(16):2546-52. PubMed ID: 22899262
[TBL] [Abstract][Full Text] [Related]
11. Process analytics for purification of monoclonal antibodies.
Flatman S; Alam I; Gerard J; Mussa N
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):79-87. PubMed ID: 17161664
[TBL] [Abstract][Full Text] [Related]
12. A practical strategy for using miniature chromatography columns in a standardized high-throughput workflow for purification development of monoclonal antibodies.
Welsh JP; Petroff MG; Rowicki P; Bao H; Linden T; Roush DJ; Pollard JM
Biotechnol Prog; 2014; 30(3):626-35. PubMed ID: 24616450
[TBL] [Abstract][Full Text] [Related]
13. Single-step affinity purification of enzyme biotherapeutics: a platform methodology for accelerated process development.
Brower KP; Ryakala VK; Bird R; Godawat R; Riske FJ; Konstantinov K; Warikoo V; Gamble J
Biotechnol Prog; 2014; 30(3):708-17. PubMed ID: 24449601
[TBL] [Abstract][Full Text] [Related]
14. Designing new monoclonal antibody purification processes using mixed-mode chromatography sorbents.
Toueille M; Uzel A; Depoisier JF; Gantier R
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(13-14):836-43. PubMed ID: 21439915
[TBL] [Abstract][Full Text] [Related]
15. A high-throughput microchip-based glycan screening assay for antibody cell culture samples.
Primack J; Flynn GC; Pan H
Electrophoresis; 2011 May; 32(10):1129-32. PubMed ID: 21500212
[TBL] [Abstract][Full Text] [Related]
16. High throughput screening based selection of phases for aqueous two-phase system-centrifugal partitioning chromatography of monoclonal antibodies.
Oelmeier SA; Ladd Effio C; Hubbuch J
J Chromatogr A; 2012 Aug; 1252():104-14. PubMed ID: 22789754
[TBL] [Abstract][Full Text] [Related]
17. Robust factor selection in early cell culture process development for the production of a biosimilar monoclonal antibody.
Sokolov M; Ritscher J; MacKinnon N; Bielser JM; Brühlmann D; Rothenhäusler D; Thanei G; Soos M; Stettler M; Souquet J; Broly H; Morbidelli M; Butté A
Biotechnol Prog; 2017 Jan; 33(1):181-191. PubMed ID: 27689949
[TBL] [Abstract][Full Text] [Related]
18. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
Bergsdorf C; Ottl J
Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
[TBL] [Abstract][Full Text] [Related]
19. High-throughput epitope binning of therapeutic monoclonal antibodies: why you need to bin the fridge.
Brooks BD; Miles AR; Abdiche YN
Drug Discov Today; 2014 Aug; 19(8):1040-4. PubMed ID: 24880105
[TBL] [Abstract][Full Text] [Related]
20. A strategy for clone selection under different production conditions.
Legmann R; Benoit B; Fedechko RW; Deppeler CL; Srinivasan S; Robins RH; McCormick EL; Ferrick DA; Rodgers ST; Russo AP
Biotechnol Prog; 2011; 27(3):757-65. PubMed ID: 21448991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
